© 2003 by BMJ Publishing Group & British Cardiac Society
JournalScan
JournalScan
| The first 150 words of the full text of this article appear below. |
Ischaemic heart disease

The evidence for the benefits of primary angioplasty over thrombolysis is strengthened further by the latest meta-analysis. Primary angioplasty was better than thrombolytic treatment at reducing overall short term death (7% v 9%; p = 0.0002), non-fatal reinfarction (3% v 7%; p < 0.0001), stroke (1% v 2%; p = 0.0004), and the combined end point of death, non-fatal reinfarction, and stroke (8% v 14%; p < 0.0001). The results seen with primary angioplasty remained better than those seen with thrombolytic treatment during long term follow up, and were independent of both the type of thrombolytic agent used, and whether or not the patient was transferred for primary angioplasty.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:1320.[CrossRef][Medline]

After a host of trials suggesting statins lower coronary heart disease (CHD)
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
